Please login to the form below

Not currently logged in
Email:
Password:

UK biotech Retrogenix appoints Matthew Britiz

He takes up role as North American business development director

Retrogenix UK biotech Matt BritzRetrogenix has appointed Matthew Britz to lead its North American business development activities.  

He joins the Manchester, UK-based biotech from US strategy consulting firm Health Advances, where he was an associate, prior to which held the post of director of business development at Envoy Therapeutics.  

He began his life sciences career at Amgen, before gaining big pharma experience from Merck & Co and then Pfizer, where he served as a senior research engineer, subsequently joining Acambis (now part of Sanofi Pasteur).  

Britz will be based at newly-opened Cambridge, US office of Retrogenix, which provides drug target screening services to global pharmaceutical clients, and tasked with supporting the company's US and Canadian growth.    

Dr Jim Freeth, managing director of Retrogenix, said: “Matt will be an excellent ambassador for Retrogenix, maintaining our strong relationships with existing clients, expanding our client base and exploring other potential market applications for the Retrogenix technology.

“Matt has first-hand experience of the challenges that our clients face in drug discovery and development, making him an incredibly valuable asset. We look forward to supporting him in this new role.”

23rd June 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics